DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B

References

• Uprichard SL, Boyd B, Althage A, et al. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci USA. 2005 Jan;102(3):773–778. doi: 10.1073/pnas.0409028102
   PubMed Web of Science ®Google Scholar
• Ganem D, Prince AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med. 2004 Mar;350(11):1118–1129. doi: 10.1056/NEJMra031087
   PubMed Web of Science ®Google Scholar
• Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016 Apr;64(1 Suppl):S84–s101. doi: 10.1016/j.jhep.2016.02.021
   PubMed Web of Science ®Google Scholar
• Revill P, Testoni B, Locarnini S, et al. Global strategies are required to cure and eliminate HBV infection. Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):239–248. doi: 10.1038/nrgastro.2016.7
   PubMed Web of Science ®Google Scholar
• Nagy PD, Pogany J. The dependence of viral RNA replication on co-opted host factors. Nat Rev Microbiol. 2011 Dec;10(2):137–149. doi: 10.1038/nrmicro2692
   PubMed Web of Science ®Google Scholar
• Nguyen DH, Ludgate L, Hu J. Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol. 2008 Aug;216(2):289–294. doi: 10.1002/jcp.21416
   PubMed Web of Science ®Google Scholar
• Nassal M. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut. 2015 Dec;64(12):1972–1984. doi: 10.1136/gutjnl-2015-309809
   PubMed Web of Science ®Google Scholar
• Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015 May;479-480:672–686. doi: 10.1016/j.virol.2015.02.031
   PubMed Web of Science ®Google Scholar
• Simon V, Bloch N, Landau NR. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat Immunol. 2015 Jun;16(6):546–553. doi: 10.1038/ni.3156
   PubMed Web of Science ®Google Scholar
• Duggal NK, Emerman M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat Rev Immunol. 2012 Oct;12(10):687–695. doi: 10.1038/nri3295
   PubMed Web of Science ®Google Scholar
• Landsberg CD, Megger DA, Hotter D, et al. A mass spectrometry-based profiling of interactomes of viral DDB1- and cullin ubiquitin ligase-binding proteins reveals NF-kappaB inhibitory activity of the HIV-2-encoded Vpx. Front Immunol. 2018;9:2978. doi: 10.3389/fimmu.2018.02978
   PubMed Web of Science ®Google Scholar
• Lucifora J, Xia Y, Reisinger F, et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science. 2014 Mar;343(6176):1221–1228. doi: 10.1126/science.1243462
   PubMed Web of Science ®Google Scholar
• Chen Y, Hu J, Cai X, et al. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription. Antiviral Res. 2018 Jan;149:16–25. doi: 10.1016/j.antiviral.2017.11.006
   PubMed Web of Science ®Google Scholar
• Wang J, Shen T, Huang X, et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. J Hepatol. 2016 Oct;65(4):700–710. doi: 10.1016/j.jhep.2016.05.029
   PubMed Web of Science ®Google Scholar
• Hu Y, Cheng X, Cao F, et al. Tavis JE. beta-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity. Antiviral Res. 2013 Sep;99(3):221–229. doi: 10.1016/j.antiviral.2013.06.007
   PubMed Web of Science ®Google Scholar
• Tavis JE, Cheng X, Hu Y, et al. The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes. PLoS Pathog. 2013 Jan;9(1):e1003125. doi: 10.1371/journal.ppat.1003125
   PubMed Web of Science ®Google Scholar
• Luo X, Huang Y, Chen Y, et al. Association of hepatitis B virus covalently closed circular DNA and human APOBEC3B in hepatitis B virus-related hepatocellular carcinoma. PloS one. 2016;11(6):e0157708. doi: 10.1371/journal.pone.0157708
   PubMed Web of Science ®Google Scholar
• Burns MB, Lackey L, Carpenter MA, et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 2013 Feb;494(7437):366–370. doi: 10.1038/nature11881
   PubMed Web of Science ®Google Scholar
• Leonard B, Hart SN, Burns MB, et al. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Res. 2013 Dec;73(24):7222–7231. doi: 10.1158/0008-5472.CAN-13-1753
   PubMed Web of Science ®Google Scholar
• Shen B, Chen Y, Hu J, et al. Hepatitis B virus X protein modulates upregulation of DHX9 to promote viral DNA replication. Cell Microbiol. 2019 Dec;21(12):1–10.
   Google Scholar
• Bonvin M, Greeve J. Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro. J Gen Virol. 2007 Dec;88(Pt 12):3270–3274. doi: 10.1099/vir.0.83149-0
   PubMed Web of Science ®Google Scholar
• Lucifora J, Protzer U. Attacking hepatitis B virus cccDNA–The holy grail to hepatitis B cure. J Hepatol. 2016 Apr;64(1 Suppl):S41–s48. doi: 10.1016/j.jhep.2016.02.009
   PubMed Web of Science ®Google Scholar
• Olson ME, Harris RS, Harki DA. APOBEC Enzymes as targets for virus and cancer Therapy. Cell Chem Biol. 2018 Jan;25(1):36–49. doi: 10.1016/j.chembiol.2017.10.007
   PubMed Web of Science ®Google Scholar
• Ma W, Ho DW, Sze KM, et al. APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase-independent activity. Mol Carcinog. 2019 May;58(5):643–653. doi: 10.1002/mc.22956
   PubMed Web of Science ®Google Scholar
• McCann JL, Klein MM, Leland EM, et al. The DNA deaminase APOBEC3B interacts with the cell cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1. J Biol Chem. 2019 Jun;294(32):12099–12111. doi: 10.1074/jbc.RA119.008443
   PubMed Web of Science ®Google Scholar
• Mishra N, Reddy KS, Timilsina U, et al. Human APOBEC3B interacts with the heterogeneous nuclear ribonucleoprotein A3 in cancer cells. J Cell Biochem. 2018 Aug;119(8):6695–6703. doi: 10.1002/jcb.26855
   PubMed Web of Science ®Google Scholar
• Lee T, Pelletier J. The biology of DHX9 and its potential as a therapeutic target. Oncotarget. 2016 Jul;7(27):42716–42739.
   PubMedGoogle Scholar
• Boeras I, Song Z, Moran A, et al. DHX9/RHA binding to the PBS-segment of the genomic RNA during HIV-1 assembly bolsters virion infectivity. J Mol Biol. 2016 Jun;428(11):2418–2429. doi: 10.1016/j.jmb.2016.04.011
   PubMed Web of Science ®Google Scholar
• Isken O, Baroth M, Grassmann CW, et al. Nuclear factors are involved in hepatitis C virus RNA replication. RNA (New York NY). 2007 Oct;13(10):1675–1692. doi: 10.1261/rna.594207
   PubMed Web of Science ®Google Scholar
• Matkovic R, Bernard E, Fontanel S, et al. The host DHX9 DExH-box helicase is recruited to chikungunya virus replication complexes for optimal genomic RNA translation. J Virol. 2019 Feb;93(4):e01764–18.
   PubMed Web of Science ®Google Scholar